Meta Pixel

News and Announcements

Crypto Investment App with Over 50% MoM Growth in the First 4 Months | $600K Raised

  • Published October 21, 2021 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

“I believe that everyone should be able to take part in exciting technologies like cryptocurrency. With this belief, Qubix focuses on making anybody feel comfortable while taking their first steps into investing in crypto or looking for a way to invest consistently in something they already understand.

In its first four months since launch, Qubix has attracted over 850 sign-ups and 250 active users. We’re asking you to join us on our journey and support us to scale our business both nationally and internationally.”

Nayef Dagher, Founder & Managing Director, Qubix

Register Interest

Executive Summary

Qubix is an Australian fintech company that makes it easy for consumers to start investing in cryptocurrency. Its app empowers and educates users to select a suggested mix of investments, set a regular investment schedule (weekly, fortnightly, or monthly), and invest for as low as A$9.

Investment Highlights

  • In Qubix’s first four months since launch, it has seen over 50% MoM growth in all categories – including signups, active users, and monthly volume.
  • Qubix is rated 4.9/5 in the Apple App Store and is also available on Google Play.
  • The cryptocurrency market is over $2T with 200M global users – a massive opportunity for Qubix to grow exponentially.

  • Qubix has successfully raised over A$600K in pre-seed funding, including A$150K via a simple agreement for future equity (SAFE) note and A$340K via crowdfunding.

  • Qubix’s shareholder and strategic partner DIJGTAL is an innovation-led design and marketing agency that leverages its proven brand-building systems to accelerate Qubix’s growth.

  • Qubix’s advisory board uses fintech and banking experience to establish best practice operations and scale the business.

Investment Offering

Qubix is looking to raise A$1.6M via ordinary shares to provide a 12 to an 18-month runway.

This capital will allow Qubix to increase its national market share, advance its product, and expand the business internationally.

Register Interest

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now